Should point out that SAVA has a much smaller pipeline than we do, though it also has a potential AD test product, which would be very valuable. SAVA market cap is twice ours, and at one point was 4 times. That was difficult to justify, and it's not surprising we had a recent market correction on that. I'm surprised there's still any major difference, but markets aren't me, and they correct over time, not at my whim. I suspect that gap will continue to close over time.
I think our commercial potential is greater.